A randomized comparison of 15- and 40-minute dosing protocols for labor augmentation and induction
- PMID: 8233251
A randomized comparison of 15- and 40-minute dosing protocols for labor augmentation and induction
Abstract
Objective: To compare two low-dose oxytocin protocols in terms of fetal distress, uterine hyperstimulation, cesarean delivery rate, maximum dose of oxytocin, and length of labor.
Methods: We randomized 865 patients into 15-minute (incremental dose 1 mU/minute until 5 mU/minute, then 1 or 2 mU/minute) or 40-minute (incremental dose 1.5 mU/minute until 7 mU/minute, then 1.5 or 3.0 mU/minute) low-dose protocols. Before oxytocin use, all subjects were stratified according to parity and purpose of oxytocin, ie, for induction or augmentation of labor.
Results: The 40-minute dosing protocol had a significantly lower maximum dose of oxytocin (augmentation, 6.5 versus 8.2 mU/minute, P < .001; induction, 11.5 versus 14.5 mU/minute, P < .001), a lower incidence of uterine hyperstimulation (augmentation, 18.8 versus 31.8%, P < .001; induction, 19.1 versus 33.0%, P < .002), and less fetal distress (augmentation, 15.5 versus 26.1%, P < .005). No significant differences were found in the cesarean rate or length of labor.
Conclusion: A dosing interval of 40 minutes led to lower incidences of uterine hyperstimulation and fetal distress, and decreased the maximum dose of oxytocin, without affecting the length of labor or the cesarean rate.
Similar articles
-
High-dose oxytocin: 20- versus 40-minute dosage interval.Obstet Gynecol. 1994 Feb;83(2):234-8. Obstet Gynecol. 1994. PMID: 8290186 Clinical Trial.
-
A prospective comparison of hourly and quarter-hourly oxytocin dose increase intervals for the induction of labor at term.Obstet Gynecol. 1990 May;75(5):757-61. Obstet Gynecol. 1990. PMID: 2325960 Clinical Trial.
-
Oxytocin augmentation of labor: a comparison of 15- and 30-minute dose increment intervals.Obstet Gynecol. 1988 Feb;71(2):147-9. Obstet Gynecol. 1988. PMID: 3336546
-
High- versus low-dose oxytocin for augmentation or induction of labor.Ann Pharmacother. 2005 Jan;39(1):95-101. doi: 10.1345/aph.1E037. Epub 2004 Nov 30. Ann Pharmacother. 2005. PMID: 15572602 Review.
-
Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin.Am J Obstet Gynecol. 2008 Jun;198(6):622.e1-7. doi: 10.1016/j.ajog.2008.01.039. Epub 2008 Mar 20. Am J Obstet Gynecol. 2008. PMID: 18355786 Review.
Cited by
-
Vaginal Birth at Term - Part 2. Guideline of the DGGG, OEGGG and SGGG (S3-Level, AWMF Registry No. 015/083, December 2020).Geburtshilfe Frauenheilkd. 2022 Nov 3;82(11):1194-1248. doi: 10.1055/a-1904-6769. eCollection 2022 Nov. Geburtshilfe Frauenheilkd. 2022. PMID: 36339632 Free PMC article.
-
Intravenous oxytocin alone for cervical ripening and induction of labour.Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD003246. doi: 10.1002/14651858.CD003246.pub2. Cochrane Database Syst Rev. 2009. PMID: 19821304 Free PMC article.
-
High-dose versus low-dose oxytocin infusion regimens for induction of labour at term.Cochrane Database Syst Rev. 2014 Oct 9;2014(10):CD009701. doi: 10.1002/14651858.CD009701.pub2. Cochrane Database Syst Rev. 2014. PMID: 25300173 Free PMC article.
-
High-dose versus low-dose oxytocin for augmentation of delayed labour.Cochrane Database Syst Rev. 2013 Jul 13;2013(7):CD007201. doi: 10.1002/14651858.CD007201.pub3. Cochrane Database Syst Rev. 2013. PMID: 23853046 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials